Warf 5 Tablet (30) is a prescription drug, available for use as Tablet. Pulmonary Embolism, Deep Vein Thrombosis, Blood Clotting Disorders are some of its major therapeutic uses. Secondary and off-label uses of Warf 5 Tablet (30) have also been mentioned below.
The optimal dosage of Warf 5 Tablet (30) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Warf 5 Tablet (30) as well, which are listed below. These side effects of Warf 5 Tablet (30) are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Warf 5 Tablet (30)'s effect during pregnancy is Moderate and Moderate while nursing. In addition, Warf 5 Tablet (30)'s effects on the liver, heart and kidney are discussed below in the Warf 5 Tablet (30) related warnings section.
Warf 5 Tablet (30) is contraindicated in people with pre-existing medical conditions like Bleeding, Diabetes, High Blood Pressure as it can result in adverse effects. Other conditions have been mentioned below in the Warf 5 Tablet (30) contraindications section.
Additionally, Warf 5 Tablet (30) may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Warf 5 Tablet (30) is considered safe while driving, and is addictive.
Warf 5 Tablet (30) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Warf 5 Tablet (30) safe for pregnant women?
Warf can have harmful effects in pregnant women. If you experience any discomfort after using Warf, then discontinue the use and take your doctor's advice.
Is the use of Warf 5 Tablet (30) safe during breastfeeding?
Warf can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Warf 5 Tablet (30) on the Kidneys?
Warf has very mild side effects on the kidneys.
What is the effect of Warf 5 Tablet (30) on the Liver?
Very few cases of side effects of Warf on the liver have been reported.
What is the effect of Warf 5 Tablet (30) on the Heart?
Use of Warf may be dangerous for the heart. Do not use it without doctor's advice.
Warf 5 Tablet (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Warf 5 Tablet (30) unless your doctor advises you to do so -
Is this Warf 5 Tablet (30) habit forming or addictive?
No, you will not get addicted to Warf 5 Tablet (30).
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Warf 5 Tablet (30) since it will not make you feel sleepy.
Is it safe?
Warf 5 Tablet (30) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Warf 5 Tablet (30) is not used to treat mental disorders.
Interaction between Food and Warf 5 Tablet (30)
Due to the absence of research, it is difficult to say how Warf 5 Tablet (30) and food will interact.
Interaction between Alcohol and Warf 5 Tablet (30)
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Warf 5 Tablet (30).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1283-1284
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 620-622
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coumadin (warfarin sodium)